Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
17 hedge funds and large institutions have $840K invested in Vaxart in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 84 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
8.97% less ownership
Funds ownership: 9.99% → 1.02% (-9%)
83% less funds holding
Funds holding: 98 → 17 (-81)
92% less capital invested
Capital invested by funds: $10.3M → $840K (-$9.47M)
96% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 84
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$77.8K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$28.9K |
| 3 |
CFO
Custos Family Office
Austin,
Texas
|
+$16.4K |
| 4 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$4.97K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$2.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.71M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.05M |
| 3 |
BlackRock
New York
|
-$802K |
| 4 |
State Street
Boston,
Massachusetts
|
-$385K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$373K |
VXRT Hedge Fund Activity: Q3 2025 in Review
17 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2025, worth a combined $840K — down 92% from $10.3M a quarter earlier.
Sellers outnumbered buyers: 84 funds closed out of VXRT and 3 opened new positions — a net loss of 81 holders — while 1 trimmed existing stakes and 5 added.
The largest buyer was Marshall Wace, adding an estimated $77.8K. The largest seller was Vanguard Group, exiting entirely with an estimated $4.71M sold.
- 17 institutional investors held Vaxart (VXRT) as of Q3 2025, down from 98 in Q2 2025.
- Funds reported $840K of Vaxart stock for Q3 2025, down 92% quarter-over-quarter.
- 3 funds opened new Vaxart positions in Q3 2025 and 84 closed out, a net change of -81 holders.
- The largest Vaxart buyer in Q3 2025 was Marshall Wace, an estimated $77.8K added.
- The largest Vaxart seller in Q3 2025 was Vanguard Group, an estimated $4.71M sold.
Based on aggregated 13F filings for Q3 2025.